Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 6 | 2022 | 4978 | 0.740 |
Why?
|
| Adenocarcinoma | 7 | 2022 | 6320 | 0.720 |
Why?
|
| Gastroenterology | 2 | 2021 | 511 | 0.680 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2016 | 95 | 0.680 |
Why?
|
| Hospitalists | 1 | 2021 | 294 | 0.610 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2022 | 1510 | 0.520 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 488 | 0.460 |
Why?
|
| Carcinoma in Situ | 2 | 2016 | 823 | 0.390 |
Why?
|
| Early Detection of Cancer | 4 | 2022 | 2932 | 0.390 |
Why?
|
| Cecum | 1 | 2010 | 232 | 0.380 |
Why?
|
| Pancreas | 2 | 2015 | 1684 | 0.350 |
Why?
|
| Esophagogastric Junction | 1 | 2010 | 296 | 0.340 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 226 | 0.340 |
Why?
|
| Stomach Neoplasms | 2 | 2015 | 1243 | 0.280 |
Why?
|
| Barrett Esophagus | 2 | 2021 | 487 | 0.260 |
Why?
|
| Carcinoma | 1 | 2016 | 2319 | 0.250 |
Why?
|
| Telomere | 2 | 2020 | 844 | 0.240 |
Why?
|
| CA-19-9 Antigen | 1 | 2020 | 97 | 0.200 |
Why?
|
| Ambulatory Care | 3 | 2021 | 2766 | 0.200 |
Why?
|
| Gallbladder Diseases | 1 | 2021 | 127 | 0.190 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6238 | 0.170 |
Why?
|
| Endosonography | 3 | 2021 | 573 | 0.170 |
Why?
|
| Telangiectasis | 1 | 2018 | 76 | 0.170 |
Why?
|
| Colonoscopy | 4 | 2022 | 1311 | 0.170 |
Why?
|
| Stents | 1 | 2010 | 3212 | 0.170 |
Why?
|
| Pancreatitis, Chronic | 2 | 2020 | 259 | 0.160 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 607 | 0.150 |
Why?
|
| Gastric Fistula | 1 | 2017 | 72 | 0.150 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2016 | 46 | 0.140 |
Why?
|
| Intestinal Fistula | 1 | 2017 | 150 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 415 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2022 | 11139 | 0.140 |
Why?
|
| Arteriovenous Fistula | 1 | 2018 | 298 | 0.140 |
Why?
|
| Colorectal Neoplasms | 3 | 2022 | 6588 | 0.140 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 814 | 0.130 |
Why?
|
| Medication Errors | 1 | 2021 | 776 | 0.130 |
Why?
|
| Pancreatic Ducts | 1 | 2015 | 333 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 20337 | 0.120 |
Why?
|
| Natural Language Processing | 1 | 2021 | 954 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2020 | 1073 | 0.120 |
Why?
|
| Pulmonary Veins | 1 | 2018 | 716 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 1157 | 0.120 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 1121 | 0.110 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 944 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 8897 | 0.110 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2016 | 373 | 0.110 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 1169 | 0.100 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2015 | 366 | 0.100 |
Why?
|
| Endoscopy | 1 | 2021 | 1756 | 0.100 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 1059 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2021 | 1980 | 0.090 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 1894 | 0.090 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2009 | 16 | 0.090 |
Why?
|
| Gastric Bypass | 1 | 2017 | 745 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2788 | 0.080 |
Why?
|
| Mass Screening | 2 | 2022 | 5219 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3561 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 1088 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2016 | 1509 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2022 | 3738 | 0.070 |
Why?
|
| Humans | 22 | 2022 | 715594 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3027 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2016 | 2326 | 0.070 |
Why?
|
| Telemedicine | 1 | 2021 | 2608 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 5069 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5032 | 0.060 |
Why?
|
| Registries | 1 | 2019 | 8042 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9813 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2018 | 6659 | 0.060 |
Why?
|
| Genomics | 1 | 2018 | 5338 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9494 | 0.050 |
Why?
|
| Metaplasia | 1 | 2021 | 310 | 0.050 |
Why?
|
| Central Nervous System Cysts | 1 | 2020 | 59 | 0.050 |
Why?
|
| Dyskeratosis Congenita | 1 | 2020 | 73 | 0.050 |
Why?
|
| Gallbladder | 1 | 2021 | 298 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2020 | 145 | 0.050 |
Why?
|
| Deep Sedation | 1 | 2021 | 113 | 0.050 |
Why?
|
| Radiography | 1 | 2010 | 6976 | 0.040 |
Why?
|
| Videoconferencing | 1 | 2021 | 192 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 285 | 0.040 |
Why?
|
| Adult | 9 | 2021 | 212237 | 0.040 |
Why?
|
| Telephone | 1 | 2021 | 631 | 0.040 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 251 | 0.040 |
Why?
|
| Pancreatic Cyst | 1 | 2020 | 351 | 0.040 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2017 | 77 | 0.040 |
Why?
|
| Jejunal Diseases | 1 | 2017 | 49 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2020 | 553 | 0.040 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 408 | 0.040 |
Why?
|
| Microcephaly | 1 | 2020 | 393 | 0.040 |
Why?
|
| Office Visits | 1 | 2021 | 627 | 0.040 |
Why?
|
| Thorax | 1 | 2019 | 514 | 0.040 |
Why?
|
| Conscious Sedation | 1 | 2021 | 513 | 0.040 |
Why?
|
| Aged | 8 | 2021 | 162392 | 0.040 |
Why?
|
| Epigenomics | 1 | 2021 | 805 | 0.040 |
Why?
|
| Ulcer | 1 | 2017 | 191 | 0.030 |
Why?
|
| Female | 11 | 2021 | 377052 | 0.030 |
Why?
|
| Drainage | 1 | 2021 | 1132 | 0.030 |
Why?
|
| Male | 11 | 2022 | 350143 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 884 | 0.030 |
Why?
|
| Education | 1 | 2018 | 543 | 0.030 |
Why?
|
| Middle Aged | 9 | 2021 | 214639 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 1356 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 819 | 0.030 |
Why?
|
| Retinal Diseases | 1 | 2020 | 670 | 0.030 |
Why?
|
| Prostate | 1 | 2022 | 1593 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 333 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2016 | 398 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1195 | 0.030 |
Why?
|
| Colectomy | 1 | 2018 | 650 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 20515 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2016 | 664 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 11664 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 4285 | 0.030 |
Why?
|
| Calcinosis | 1 | 2020 | 1453 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2021 | 2589 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 58293 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 803 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 4903 | 0.030 |
Why?
|
| Gastrectomy | 1 | 2015 | 547 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 1565 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2129 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1723 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2019 | 2538 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2020 | 2922 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2015 | 0.020 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2009 | 22 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1699 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2009 | 48 | 0.020 |
Why?
|
| Retina | 1 | 2020 | 2626 | 0.020 |
Why?
|
| Diarrhea | 1 | 2017 | 1371 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2009 | 140 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2022 | 9977 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 2031 | 0.020 |
Why?
|
| Seizures | 1 | 2020 | 2579 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8742 | 0.020 |
Why?
|
| Risk Factors | 3 | 2021 | 70931 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 2528 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 7737 | 0.020 |
Why?
|
| Mutation | 2 | 2021 | 29253 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3670 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 72448 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 2345 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2009 | 484 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14887 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 13215 | 0.020 |
Why?
|
| Incidence | 1 | 2022 | 20761 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 792 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2016 | 40040 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 16302 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2559 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 56140 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15185 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13219 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8560 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 85064 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12495 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23482 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 8801 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17399 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2017 | 12547 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 41184 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40889 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 5921 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 12530 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15101 | 0.010 |
Why?
|
| United States | 1 | 2020 | 67895 | 0.010 |
Why?
|
| Child | 1 | 2020 | 74413 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 62039 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 169173 | 0.000 |
Why?
|
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(71)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_